Guggenheim Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-26,426
Closed -$523K 2157
2020
Q4
$523K Sell
26,426
-93,062
-78% -$1.84M ﹤0.01% 1616
2020
Q3
$1.56M Sell
119,488
-16,054
-12% -$209K 0.01% 999
2020
Q2
$1.54M Buy
135,542
+38,852
+40% +$441K 0.01% 993
2020
Q1
$1.38M Sell
96,690
-17,762
-16% -$254K 0.01% 943
2019
Q4
$3.12M Buy
114,452
+8,780
+8% +$239K 0.02% 849
2019
Q3
$3.03M Sell
105,672
-12,768
-11% -$366K 0.02% 839
2019
Q2
$3.29M Buy
118,440
+16,807
+17% +$467K 0.03% 814
2019
Q1
$3.38M Sell
101,633
-97,526
-49% -$3.24M 0.03% 823
2018
Q4
$5.79M Sell
199,159
-2,637
-1% -$76.7K 0.05% 489
2018
Q3
$9.28M Sell
201,796
-119,080
-37% -$5.48M 0.06% 374
2018
Q2
$12M Sell
320,876
-46,093
-13% -$1.72M 0.08% 273
2018
Q1
$10.8M Sell
366,969
-5,134
-1% -$152K 0.03% 652
2017
Q4
$12.8M Sell
372,103
-30,773
-8% -$1.06M 0.03% 617
2017
Q3
$14.6M Buy
402,876
+203,323
+102% +$7.36M 0.03% 570
2017
Q2
$5.16M Sell
199,553
-13,491
-6% -$349K 0.01% 1001
2017
Q1
$4.09M Buy
213,044
+60,418
+40% +$1.16M 0.01% 1148
2016
Q4
$2.54M Sell
152,626
-13,420
-8% -$224K 0.01% 1486
2016
Q3
$3.42M Buy
166,046
+4,609
+3% +$94.8K 0.01% 1250
2016
Q2
$4.94M Buy
161,437
+6,124
+4% +$187K 0.02% 1006
2016
Q1
$5.81M Sell
155,313
-61,640
-28% -$2.31M 0.02% 913
2015
Q4
$9.36M Sell
216,953
-55,751
-20% -$2.41M 0.03% 770
2015
Q3
$10.2M Sell
272,704
-95,861
-26% -$3.59M 0.03% 736
2015
Q2
$12.5M Buy
368,565
+21,181
+6% +$720K 0.03% 751
2015
Q1
$12.3M Buy
347,384
+48,011
+16% +$1.7M 0.03% 772
2014
Q4
$10.2M Sell
299,373
-46,132
-13% -$1.57M 0.03% 828
2014
Q3
$13.3M Buy
345,505
+19,107
+6% +$737K 0.03% 778
2014
Q2
$12.7M Buy
326,398
+53,056
+19% +$2.07M 0.03% 782
2014
Q1
$9.35M Sell
273,342
-6,374
-2% -$218K 0.03% 873
2013
Q4
$5.87M Buy
279,716
+28,011
+11% +$588K 0.02% 1014
2013
Q3
$5.92M Buy
251,705
+55,277
+28% +$1.3M 0.02% 1014
2013
Q2
$5.28M Buy
+196,428
New +$5.28M 0.02% 1023